Major Adverse Cardiovascular Events and Cause-Specific Mortality After Hospitalisation in COPD
Open Access
- 1 July 2025
- journal article
- research article
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 20, 2549-2560
Abstract
Purpose: People with chronic obstructive pulmonary disease (COPD) are at elevated risk of cardiovascular events and mortality. We aimed to determine, in a COPD population, the relationship between hospitalization and post-discharge one-year rates of (i) major adverse cardiovascular events (MACE) and (ii) cause-specific mortality. Patients and Methods: We conducted a prospective cohort study on a COPD population, between 01/01/2010 and 31/12/2019, using nationally-representative, routinely collected electronic healthcare records in England (Clinical Practice Research Datalink Aurum primary care data, linked with secondary care [Hospital Episode Statistics], and mortality [Office of National Statistics] data). The exposure was ≥one hospitalization, and the control group was no hospitalization. Outcomes were one-year rates of (i) non-fatal MACE (acute coronary syndrome, arrhythmia, heart failure, or ischemic stroke) and (ii) cause-specific mortality. Exposures were stratified by hospitalization type (elective and emergency) and cause (all-cause, cardiovascular, respiratory, and non-cardiorespiratory). We implemented adjusted Cox proportional hazard regression models, and sensitivity doubly robust propensity score-adjusted models. Results: Hospitalized COPD patients had significantly higher rates (incidence rate [IR, per 1000 person-years]; adjusted hazard ratio {aHR} [95% confidence interval {95% CI}] of MACE in the year following hospitalization, whether elective (IR=33.3; 7.04 [6.19– 8.07]) or emergency (IR=70.0; 8.85 [7.78– 10.06]), versus those without hospitalization (IR=3.4). Emergency hospitalization was associated with increased all-cause mortality (IR=146.5; 2.49 [2.37– 2.61]), regardless of hospitalization cause, compared to those not hospitalized (IR=30.3). Elective hospitalization was also associated with increased all-cause mortality (IR=54.6; 1.32 [1.25– 1.38]), except for cardiovascular elective hospitalization (1.00 [0.89– 1.12]). Cause-specific mortality was influenced largely by hospitalization cause. Conclusion: Hospitalized COPD patients experienced increased subsequent one-year MACE and mortality rates, regardless of hospitalization cause or type. Hospitalization for any reason in COPD patients provides an opportunity to provide primary prevention for MACE.Keywords
This publication has 28 references indexed in Scilit:
- Defining the relationship between COPD and CVD: what are the implications for clinical practice?Therapeutic Advances in Respiratory Disease, 2018
- Comparison of Propensity Score Methods and Covariate AdjustmentJACC, 2017
- Incidence, survival and cause-specific mortality in alcoholic liver disease: a population-based cohort studyScandinavian Journal of Gastroenterology, 2016
- Validation of the Recording of Acute Exacerbations of COPD in UK Primary Care Electronic Healthcare RecordsPLOS ONE, 2016
- Independent predictors of major adverse cardiovascular events in emergency department patients who are hospitalised with a suspected infection: a retrospective cohort studyBMJ Open, 2016
- Association Between Hospitalization for Pneumonia and Subsequent Risk of Cardiovascular DiseaseJAMA, 2015
- Validation of chronic obstructive pulmonary disease recording in the Clinical Practice Research Datalink (CPRD-GOLD)BMJ Open, 2014
- Acute Myocardial Infarction in Hospitalized Patients with Community‐Acquired PneumoniaClinical Infectious Diseases, 2008
- Improving the Comparability of Diabetes Mortality Statistics in the U.S. and MexicoDiabetes Care, 2008
- Recent respiratory infection and risk of cardiovascular disease: case-control study through a general practice databaseEuropean Heart Journal, 2007